NAFDAC issues alert about counterfeit Oxycontin pain medication in circulation.
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a stark warning about the circulation of falsified Oxycontin 80mg (oxycodone hydrochloride) tablets, recently detected in an unregulated market in Switzerland. The agency’s alert, released on Thursday, reveals the potential dangers posed by the counterfeit medication, which does not contain the active…
